Chardan Capital Markets Downgrades Avidity Biosciences (RNA) to Neutral Nov 7, 2025 04:09AM
Chardan Capital Markets Downgrades Avidity Biosciences (RNA) to Neutral Oct 28, 2025 03:24AM
Avidity Biosciences to Participate in Upcoming Investor Conference Oct 16, 2025 09:00AM
Avidity Biosciences to Participate in Upcoming Investor Conference Sep 25, 2024 09:00AM
Avidity Biosciences Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares Aug 19, 2024 09:00AM


Aug 15, 2024 06:17AM Avidity Biosciences Inc. (RNA) Prices Upsized 7.32M Share Offering at $41/sh
Aug 14, 2024 08:30PM Avidity Biosciences Announces Pricing of Upsized Public Offering of Common Stock
Feb 29, 2024 07:01AM Avidity Biosciences Inc. (RNA) Prices 15.22M Share Offering at $16.50/sh
Feb 29, 2024 07:00AM Avidity Biosciences Announces Oversubscribed $400 Million Private Placement
Sep 25, 2023 09:00AM Avidity Biosciences to Participate in Upcoming Investor Conferences
Jul 20, 2022 06:16AM UPDATE: Chardan Capital Markets Starts Avidity Biosciences (RNA) at Buy
Aug 31, 2021 09:30AM Avidity Biosciences to Participate in Upcoming Investor Conferences
Sep 28, 2020 04:05PM Avidity Biosciences to Present at the Virtual Chardan 4th Annual Genetic Medicines Conference 2020